134 related articles for article (PubMed ID: 35324065)
1. Alcohol-related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis.
Costentin CE; Minoves M; Kotzki S; Farges O; Goutté N; Decaens T; Bailly S
Liver Int; 2022 Jul; 42(7):1638-1647. PubMed ID: 35324065
[TBL] [Abstract][Full Text] [Related]
2. Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients.
Vaz J; Strömberg U; Midlöv P; Eriksson B; Buchebner D; Hagström H
J Intern Med; 2023 Feb; 293(2):184-199. PubMed ID: 36166276
[TBL] [Abstract][Full Text] [Related]
3. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.
Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H
J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015
[TBL] [Abstract][Full Text] [Related]
4. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
[TBL] [Abstract][Full Text] [Related]
5. Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis.
Tsai MC; Yang SS; Lin CC; Wang WL; Hsu YC; Chen YS; Hu JT; Lin JY; Yu ML; Lin CW
JAMA Netw Open; 2022 Jul; 5(7):e2223511. PubMed ID: 35877121
[TBL] [Abstract][Full Text] [Related]
6. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.
Suh B; Yun JM; Park S; Shin DW; Lee TH; Yang HK; Ahn E; Lee H; Park JH; Cho B
Cancer; 2015 Nov; 121(21):3818-25. PubMed ID: 26178294
[TBL] [Abstract][Full Text] [Related]
7. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
8. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
Mun BS; Ahn HS; Ahn DS; Lee SO
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
[TBL] [Abstract][Full Text] [Related]
9. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.
Yi SW; Choi JS; Yi JJ; Lee YH; Han KJ
Cancer; 2018 Jul; 124(13):2748-2757. PubMed ID: 29669170
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
Costentin CE; Mourad A; Lahmek P; Causse X; Pariente A; Hagège H; Dobrin AS; Becker C; Marks B; Bader R; Condat B; Héluwaert F; Seitz JF; Lesgourgues B; Denis J; Deuffic-Burban S; Rosa I; Decaens T;
Cancer; 2018 May; 124(9):1964-1972. PubMed ID: 29589878
[TBL] [Abstract][Full Text] [Related]
12. Alcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma.
Abe H; Aida Y; Ishiguro H; Yoshizawa K; Miyazaki T; Itagaki M; Sutoh S; Aizawa Y
World J Gastroenterol; 2013 Jan; 19(1):78-85. PubMed ID: 23326166
[TBL] [Abstract][Full Text] [Related]
13. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder.
Chiu WC; Shan JC; Yang YH; Chen VC; Chen PC
Drug Alcohol Depend; 2021 Nov; 228():109096. PubMed ID: 34600254
[TBL] [Abstract][Full Text] [Related]
14. Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study.
Vandenbulcke H; Moreno C; Colle I; Knebel JF; Francque S; Sersté T; George C; de Galocsy C; Laleman W; Delwaide J; Orlent H; Lasser L; Trépo E; Van Vlierberghe H; Michielsen P; van Gossum M; de Vos M; Marot A; Doerig C; Henrion J; Deltenre P
J Hepatol; 2016 Sep; 65(3):543-51. PubMed ID: 27180899
[TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study.
Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage C; Gunathilaka B; Jayathunge S; de Silva HJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):401-5. PubMed ID: 26256085
[TBL] [Abstract][Full Text] [Related]
17. Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study.
Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
Scand J Gastroenterol; 2019 Aug; 54(8):1027-1032. PubMed ID: 31389730
[No Abstract] [Full Text] [Related]
18. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis.
Miyakawa H; Izumi N; Marumo F; Sato C
Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):91A-94A. PubMed ID: 8659700
[TBL] [Abstract][Full Text] [Related]
19. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Seo W; Gao Y; He Y; Sun J; Xu H; Feng D; Park SH; Cho YE; Guillot A; Ren T; Wu R; Wang J; Kim SJ; Hwang S; Liangpunsakul S; Yang Y; Niu J; Gao B
J Hepatol; 2019 Nov; 71(5):1000-1011. PubMed ID: 31279903
[TBL] [Abstract][Full Text] [Related]
20. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
van der Meer AJ; Feld JJ; Hofer H; Almasio PL; Calvaruso V; Fernández-Rodríguez CM; Aleman S; Ganne-Carrié N; D'Ambrosio R; Pol S; Trapero-Marugan M; Maan R; Moreno-Otero R; Mallet V; Hultcrantz R; Weiland O; Rutter K; Di Marco V; Alonso S; Bruno S; Colombo M; de Knegt RJ; Veldt BJ; Hansen BE; Janssen HLA
J Hepatol; 2017 Mar; 66(3):485-493. PubMed ID: 27780714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
